Financhill
Buy
55

ARVN Quote, Financials, Valuation and Earnings

Last price:
$12.55
Seasonality move :
38.05%
Day range:
$12.34 - $13.09
52-week range:
$5.90 - $26.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.95x
P/B ratio:
1.44x
Volume:
1.8M
Avg. volume:
2.6M
1-year change:
-50.57%
Market cap:
$813.7M
Revenue:
$263.4M
EPS (TTM):
-$0.80

Analysts' Opinion

  • Consensus Rating
    Arvinas, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 9 Hold ratings, and 1 Sell rating.
  • Price Target Downside
    According to analysts' consensus price target of $12.31, Arvinas, Inc. has an estimated downside of -2.82% from its current price of $12.55.
  • Price Target Upside
    According to analysts, the highest upside price target is $18.00 representing -100% upside increase from its current price of $12.55.

Fair Value

  • According to the consensus of 17 analysts, Arvinas, Inc. has -2.82% downside to fair value with a price target of $12.31 per share.

ARVN vs. S&P 500

  • Over the past 5 trading days, Arvinas, Inc. has overperformed the S&P 500 by 4.53% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Arvinas, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Arvinas, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Arvinas, Inc. reported revenues of $41.9M.

Earnings Growth

  • Arvinas, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Arvinas, Inc. reported earnings per share of -$0.48.
Enterprise value:
35.6M
EV / Invested capital:
0.06x
Price / LTM sales:
2.95x
EV / EBIT:
--
EV / Revenue:
0.11x
PEG ratio (5yr expected):
-1.15x
EV / Free cash flow:
0.91x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$306.7M
Return On Assets:
-5.84%
Net Income Margin (TTM):
-18.73%
Return On Equity:
-9.81%
Return On Invested Capital:
-9.68%
Operating Margin:
-105.01%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $159.6M $161.1M $312.3M $102.4M $41.9M
Gross Profit $152.5M $53.6M $306.7M -- $40.6M
Operating Income -$311.6M -$357.4M -$101.3M -$60.3M -$44M
EBITDA -$304.5M -- -$95.7M -- -$42.7M
Diluted EPS -$5.53 -$4.67 -$0.80 -$0.68 -$0.48
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $1.6B $1.3B $1B $1.1B $826.3M
Total Assets $1.6B $1.3B $1.1B $1.2B $844.3M
Current Liabilities $182.5M $244.6M $317.3M $275.9M $144.9M
Total Liabilities $787.1M $713.3M $601.1M -- $279.9M
Total Equity $817.7M $621.5M $457.2M $586M $564.4M
Total Debt $5.3M $4.1M $2.1M -- $7.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$335.9M -$258.3M -- -- -$59.1M
Cash From Investing $276.6M -$117.9M -- -- $63.5M
Cash From Financing $40.4M $342.2M -- -- -$17.8M
Free Cash Flow -$339.8M -$259.9M -- -- -$59.2M
ARVN
Sector
Market Cap
$813.7M
$28.4M
Price % of 52-Week High
47.31%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
2.63%
-1.32%
1-Year Price Total Return
-47.62%
-22.19%
Beta (5-Year)
2.446
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $12.20
200-day SMA
Buy
Level $8.86
Bollinger Bands (100)
Buy
Level 7.2 - 10.5
Chaikin Money Flow
Sell
Level -8.3M
20-day SMA
Buy
Level $11.49
Relative Strength Index (RSI14)
Buy
Level 61.26
ADX Line
Buy
Level 38.49
Williams %R
Neutral
Level -36.7299
50-day SMA
Buy
Level $10.22
MACD (12, 26)
Buy
Level 0.68
25-day Aroon Oscillator
Buy
Level 36
On Balance Volume
Neutral
Level 46.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.0662)
Sell
CA Score (Annual)
Level (-1.1122)
Sell
Beneish M-Score (Annual)
Level (-1.0332)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (0.9545)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.

Stock Forecast FAQ

In the current month, ARVN has received 7 Buy ratings 9 Hold ratings, and 1 Sell ratings. The ARVN average analyst price target in the past 3 months is $12.31.

  • Where Will Arvinas, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Arvinas, Inc. share price will drop to $12.31 per share over the next 12 months.

  • What Do Analysts Say About Arvinas, Inc.?

    Analysts are divided on their view about Arvinas, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arvinas, Inc. is a Sell and believe this share price will rise from its current level to $6.00.

  • What Is Arvinas, Inc.'s Price Target?

    The price target for Arvinas, Inc. over the next 1-year time period is forecast to be $12.31 according to 17 Wall Street analysts, 7 of them rate the stock a Buy, 1 rates the stock a Sell, and 9 analysts rate the stock a Hold.

  • Is ARVN A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Arvinas, Inc. is a Hold. 9 of 17 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of ARVN?

    You can purchase shares of Arvinas, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arvinas, Inc. shares.

  • What Is The Arvinas, Inc. Share Price Today?

    Arvinas, Inc. was last trading at $12.55 per share. This represents the most recent stock quote for Arvinas, Inc.. Yesterday, Arvinas, Inc. closed at $12.55 per share.

  • How To Buy Arvinas, Inc. Stock Online?

    In order to purchase Arvinas, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock